Eli Lilly Reports Strong Sales Growth for Diabetes and Obesity Drugs, Raising Annual Revenue Outlook
Eli Lilly, a leading pharmaceutical company, has reported impressive financial results for the first three months of 2026, driven largely […]
Eli Lilly, a leading pharmaceutical company, has reported impressive financial results for the first three months of 2026, driven largely […]
Starting January 1, 2026, pharmaceutical companies in Europe will no longer be allowed to use rabbit testing to check if
At a recent cancer research meeting, several important updates were shared about new treatments and trends in the pharmaceutical industry.
Regeneron Pharmaceuticals has made two major announcements this week. First, the company has agreed to a new deal with the
Sanofi, a leading French pharmaceutical company, has received positive news about its multiple sclerosis (MS) drug called tolebrutinib. The European
A clinical trial for a new personalized cancer vaccine called TG4050 has reached a key step. The study, which is
A new experimental medication called adibelivir (IM-250), developed by Innovative Molecules, is showing strong potential in early studies to treat
A new and exciting type of medical treatment called ‘in vivo cell therapy’ is now being tested for the first
Eli Lilly, the company behind the newly approved obesity medication called Foundayo (also known as orforglipron), has shared exciting new
A recent study has found that using food packaging films to store certain medications can help maintain their stability, especially